PFRM3 Stock Overview
Engages in the distribution of pharmaceutical products in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Profarma Distribuidora de Produtos Farmacêuticos S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$6.45 |
| 52 Week High | R$7.86 |
| 52 Week Low | R$4.41 |
| Beta | 0.97 |
| 1 Month Change | -7.86% |
| 3 Month Change | 9.32% |
| 1 Year Change | 18.78% |
| 3 Year Change | 17.27% |
| 5 Year Change | 1.57% |
| Change since IPO | -74.95% |
Recent News & Updates
Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Has A Somewhat Strained Balance Sheet
Dec 19
Returns On Capital Are Showing Encouraging Signs At Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3)
Nov 02Recent updates
Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Has A Somewhat Strained Balance Sheet
Dec 19Returns On Capital Are Showing Encouraging Signs At Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3)
Nov 02Shareholders Will Be Pleased With The Quality of Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Earnings
Aug 14Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) 28% Price Boost Is Out Of Tune With Earnings
Mar 01These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Feb 21Returns On Capital Are Showing Encouraging Signs At Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3)
Nov 04Investors Will Want Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Growth In ROCE To Persist
Aug 03These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Jun 08These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Sep 26Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Shares Fly 26% But Investors Aren't Buying For Growth
Jan 01Here's Why Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Weighed Down By Its Debt Load
May 28Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Might Have The Makings Of A Multi-Bagger
May 07How Much Of Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Do Institutions Own?
Mar 10Are Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 02
Is Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Using Too Much Debt?
Jan 05What Type Of Shareholders Make Up Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) Share Registry?
Dec 10Shareholder Returns
| PFRM3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 0.2% | -10.6% | -7.2% |
| 1Y | 18.8% | -31.7% | -11.5% |
Return vs Industry: PFRM3 exceeded the BR Healthcare industry which returned -31.7% over the past year.
Return vs Market: PFRM3 exceeded the BR Market which returned -11.5% over the past year.
Price Volatility
| PFRM3 volatility | |
|---|---|
| PFRM3 Average Weekly Movement | 6.2% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in BR Market | 9.2% |
| 10% least volatile stocks in BR Market | 2.7% |
Stable Share Price: PFRM3 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: PFRM3's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | n/a | Sammy Birmarcker | www.profarma.com.br |
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution of pharmaceutical products in Brazil. It provides pharmaceutical, personal care and beauty products. The company operates retail stores under the Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosário brands.
Profarma Distribuidora de Produtos Farmacêuticos S.A. Fundamentals Summary
| PFRM3 fundamental statistics | |
|---|---|
| Market cap | R$760.19m |
| Earnings (TTM) | R$107.45m |
| Revenue (TTM) | R$9.34b |
7.4x
P/E Ratio0.1x
P/S RatioIs PFRM3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PFRM3 income statement (TTM) | |
|---|---|
| Revenue | R$9.34b |
| Cost of Revenue | R$7.91b |
| Gross Profit | R$1.44b |
| Other Expenses | R$1.33b |
| Earnings | R$107.45m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 27, 2025
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 15.40% |
| Net Profit Margin | 1.15% |
| Debt/Equity Ratio | 45.9% |
How did PFRM3 perform over the long term?
See historical performance and comparisonDividends
8.9%
Current Dividend Yield44%
Payout RatioDoes PFRM3 pay a reliable dividends?
See PFRM3 dividend history and benchmarks| Profarma Distribuidora de Produtos Farmacêuticos dividend dates | |
|---|---|
| Ex Dividend Date | Jan 02 2025 |
| Dividend Pay Date | Jan 15 2025 |
| Days until Ex dividend | 13 days |
| Days until Dividend pay date | 26 days |
Does PFRM3 pay a reliable dividends?
See PFRM3 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 22:59 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Profarma Distribuidora de Produtos Farmacêuticos S.A. is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Diego Moreno | BofA Global Research |
| Guilherme Assis | Brasil Plural |
| Joao dos Santos | BTG Pactual |